Derek Archila
Stock Analyst at Wells Fargo
(4.84)
# 426
Out of 5,022 analysts
925
Total ratings
51.6%
Success rate
18.2%
Average return
Main Sectors:
Stocks Rated by Derek Archila
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INCY Incyte | Rated: Hold | $116 → $128 | $115.30 | +11.01% | 42 | Oct 1, 2026 | |
| QTTB Q32 Bio | Reiterated: Buy | $59 | $8.23 | +616.89% | 11 | Oct 1, 2026 | |
| KYTX Kyverna Therapeutics | Reiterated: Buy | $33 | $6.22 | +430.55% | 16 | Sep 25, 2026 | |
| CLDX Celldex Therapeutics | Reiterated: Buy | $72 | $31.65 | +127.49% | 24 | Sep 23, 2026 | |
| ALXO ALX Oncology Holdings | Reiterated: Buy | $5 | $1.22 | +309.84% | 2 | Sep 21, 2026 | |
| IRON Disc Medicine | Rated: Buy | $79 → $86 | $64.51 | +33.31% | 5 | Sep 16, 2026 | |
| PYXS Pyxis Oncology | Reiterated: Buy | $12 → $19 | $2.14 | +787.85% | 3 | Sep 10, 2026 | |
| ALMS Alumis | Reiterated: Buy | $25 | $6.85 | +264.96% | 12 | Sep 9, 2026 | |
| SEPN Septerna | Reiterated: Buy | $50 | $37.71 | +32.59% | 14 | Sep 9, 2026 | |
| XFOR X4 Pharmaceuticals | Reiterated: Buy | $11 | $2.83 | +288.69% | 2 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $25 | $22.99 | +8.74% | 25 | Sep 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $116 → $151 | $107.39 | +40.61% | 25 | Aug 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $1,350 → $1,415 | $919.21 | +53.94% | 79 | Aug 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $326 | $227.87 | +43.06% | 45 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 | $4.19 | +544.39% | 22 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 | $2.95 | +238.98% | 14 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $98 → $102 | $67.25 | +51.67% | 7 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $1 | $0.2872 | +248.19% | 13 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $15 → $11 | $7.41 | +48.45% | 26 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $12.21 | +104.83% | 13 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $55 | $33.28 | +65.26% | 3 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $31 | $19.40 | +59.79% | 19 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $155 | $92.83 | +66.97% | 61 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $29 | $10.50 | +176.19% | 17 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $33.62 | +33.85% | 29 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $30 → $35 | $58.39 | -40.06% | 26 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $479 → $376 | $219.72 | +71.13% | 4 | Jan 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $51 → $81 | $48.53 | +66.91% | 27 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $56 | $61.31 | -8.66% | 4 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 | $28.64 | +8.24% | 1 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $73 | $63.46 | +15.03% | 1 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $101 | $22.54 | +348.09% | 1 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $40 → $30 | $15.35 | n/a | 13 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 → $2 | $2.00 | n/a | 16 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $14 | $25.15 | n/a | 10 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 → $5 | $2.52 | n/a | 17 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $180 | $49.02 | n/a | 1 | Dec 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | $11.36 | $1.26 | n/a | 1 | Dec 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 | $1.41 | n/a | 11 | Jun 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 | $0.3476 | n/a | 34 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 | $7.36 | n/a | 20 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $41.40 | n/a | 27 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $96 → $97 | $29.37 | n/a | 15 | May 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $126 → $130 | $499.40 | n/a | 10 | May 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 → $6 | $10.55 | n/a | 20 | May 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 | $12.33 | n/a | 28 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $29.94 | n/a | 11 | Apr 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €16.02 → €16.91 | €3.15 | n/a | 2 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $19 | $3.56 | n/a | 4 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €92.69 → €96.00 | €25.66 | n/a | 2 | Feb 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €11.00 | €9.10 | n/a | 7 | Sep 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $25.21 | n/a | 14 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.63 | n/a | 31 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $9.99 | n/a | 12 | Apr 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.012 | n/a | 11 | Mar 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $98 | $14.26 | n/a | 6 | Mar 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.8112 | n/a | 8 | Nov 9, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $17.60 | n/a | 1 | Oct 3, 2017 |
Incyte
Oct 1, 2026
Rated: Hold
Price Target: $116 → $128
Current: $115.30
Upside: +11.01%
Q32 Bio
Oct 1, 2026
Reiterated: Buy
Price Target: $59
Current: $8.23
Upside: +616.89%
Kyverna Therapeutics
Sep 25, 2026
Reiterated: Buy
Price Target: $33
Current: $6.22
Upside: +430.55%
Celldex Therapeutics
Sep 23, 2026
Reiterated: Buy
Price Target: $72
Current: $31.65
Upside: +127.49%
ALX Oncology Holdings
Sep 21, 2026
Reiterated: Buy
Price Target: $5
Current: $1.22
Upside: +309.84%
Disc Medicine
Sep 16, 2026
Rated: Buy
Price Target: $79 → $86
Current: $64.51
Upside: +33.31%
Pyxis Oncology
Sep 10, 2026
Reiterated: Buy
Price Target: $12 → $19
Current: $2.14
Upside: +787.85%
Alumis
Sep 9, 2026
Reiterated: Buy
Price Target: $25
Current: $6.85
Upside: +264.96%
Septerna
Sep 9, 2026
Reiterated: Buy
Price Target: $50
Current: $37.71
Upside: +32.59%
X4 Pharmaceuticals
Sep 9, 2026
Reiterated: Buy
Price Target: $11
Current: $2.83
Upside: +288.69%
Sep 1, 2026
Reiterated: Hold
Price Target: $25
Current: $22.99
Upside: +8.74%
Aug 27, 2026
Rated: Buy
Price Target: $116 → $151
Current: $107.39
Upside: +40.61%
Aug 26, 2026
Rated: Buy
Price Target: $1,350 → $1,415
Current: $919.21
Upside: +53.94%
Aug 14, 2026
Reiterated: Buy
Price Target: $326
Current: $227.87
Upside: +43.06%
Aug 13, 2026
Reiterated: Buy
Price Target: $27
Current: $4.19
Upside: +544.39%
Aug 12, 2026
Rated: Buy
Price Target: $10
Current: $2.95
Upside: +238.98%
Aug 11, 2026
Reiterated: Buy
Price Target: $98 → $102
Current: $67.25
Upside: +51.67%
Aug 10, 2026
Rated: Hold
Price Target: $1
Current: $0.2872
Upside: +248.19%
Aug 5, 2026
Downgraded: Hold
Price Target: $15 → $11
Current: $7.41
Upside: +48.45%
Aug 4, 2026
Reiterated: Buy
Price Target: $25
Current: $12.21
Upside: +104.83%
Jul 28, 2026
Reiterated: Buy
Price Target: $30 → $55
Current: $33.28
Upside: +65.26%
Jul 20, 2026
Rated: Buy
Price Target: $31
Current: $19.40
Upside: +59.79%
Jul 16, 2026
Rated: Buy
Price Target: $155
Current: $92.83
Upside: +66.97%
Jun 24, 2026
Rated: Buy
Price Target: $29
Current: $10.50
Upside: +176.19%
May 21, 2026
Reiterated: Buy
Price Target: $45
Current: $33.62
Upside: +33.85%
Feb 11, 2026
Reiterated: Hold
Price Target: $30 → $35
Current: $58.39
Upside: -40.06%
Jan 20, 2026
Reiterated: Hold
Price Target: $479 → $376
Current: $219.72
Upside: +71.13%
Dec 16, 2025
Reiterated: Buy
Price Target: $51 → $81
Current: $48.53
Upside: +66.91%
Dec 16, 2025
Reiterated: Sell
Price Target: $56
Current: $61.31
Upside: -8.66%
Oct 17, 2025
Reiterated: Buy
Price Target: $31
Current: $28.64
Upside: +8.24%
Oct 17, 2025
Reiterated: Buy
Price Target: $73
Current: $63.46
Upside: +15.03%
Oct 17, 2025
Reiterated: Buy
Price Target: $101
Current: $22.54
Upside: +348.09%
Aug 12, 2025
Reiterated: Hold
Price Target: $40 → $30
Current: $15.35
Upside: n/a
Aug 8, 2025
Reiterated: Hold
Price Target: $3 → $2
Current: $2.00
Upside: n/a
Aug 7, 2025
Reiterated: Hold
Price Target: $14
Current: $25.15
Upside: n/a
Aug 6, 2025
Reiterated: Hold
Price Target: $6 → $5
Current: $2.52
Upside: n/a
Dec 6, 2021
Initiated Coverage: Buy
Price Target: $180
Current: $49.02
Upside: n/a
Dec 6, 2021
Initiated Coverage: Sell
Price Target: $11.36
Current: $1.26
Upside: n/a
Jun 13, 2021
Rated: Buy
Price Target: $12
Current: $1.41
Upside: n/a
May 13, 2021
Reiterated: Buy
Price Target: $27
Current: $0.3476
Upside: n/a
May 13, 2021
Reiterated: Hold
Price Target: $3
Current: $7.36
Upside: n/a
May 13, 2021
Reiterated: Buy
Price Target: $30
Current: $41.40
Upside: n/a
May 9, 2021
Reiterated: Hold
Price Target: $96 → $97
Current: $29.37
Upside: n/a
May 6, 2021
Reiterated: Hold
Price Target: $126 → $130
Current: $499.40
Upside: n/a
May 3, 2021
Reiterated: Hold
Price Target: $7 → $6
Current: $10.55
Upside: n/a
Apr 29, 2021
Reiterated: Hold
Price Target: $6
Current: $12.33
Upside: n/a
Apr 28, 2021
Reiterated: Buy
Price Target: $13
Current: $29.94
Upside: n/a
Mar 5, 2021
Reiterated: Buy
Price Target: €16.02 → €16.91
Current: €3.15
Upside: n/a
Mar 5, 2021
Reiterated: Buy
Price Target: $18 → $19
Current: $3.56
Upside: n/a
Feb 19, 2021
Reiterated: Hold
Price Target: €92.69 → €96.00
Current: €25.66
Upside: n/a
Sep 30, 2020
Reiterated: Buy
Price Target: €11.00
Current: €9.10
Upside: n/a
Jul 10, 2020
Rated: Hold
Price Target: n/a
Current: $25.21
Upside: n/a
Jul 10, 2020
Rated: Hold
Price Target: n/a
Current: $4.63
Upside: n/a
Apr 2, 2018
Reiterated: Buy
Price Target: $13
Current: $9.99
Upside: n/a
Mar 22, 2018
Reiterated: Buy
Price Target: n/a
Current: $0.012
Upside: n/a
Mar 5, 2018
Reiterated: Buy
Price Target: $98
Current: $14.26
Upside: n/a
Nov 9, 2017
Reiterated: Hold
Price Target: n/a
Current: $0.8112
Upside: n/a
Oct 3, 2017
Reiterated: Hold
Price Target: n/a
Current: $17.60
Upside: n/a